Evidence indicates that loss of the anti-proliferative responsiveness to TGF-β is a characteristic of many tumor cells [11-13], suggesting potential roles of TGF-β and substantial components of the TGF-β signal transduction pathway as tumor suppressors [14]. Here, TGFB1 is linked to neoplasm.